• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

IT firms prepare to merge

Article

Cerner is hatching plans to acquire Dynamic Healthcare Technologies of Lake Mary, FL, in a stock transaction valued at $2.2 million. The deal is expected to close before the end of this year, pending Dynamic shareholder and regulatory approvals. Dynamic

Cerner is hatching plans to acquire Dynamic Healthcare Technologies of Lake Mary, FL, in a stock transaction valued at $2.2 million. The deal is expected to close before the end of this year, pending Dynamic shareholder and regulatory approvals. Dynamic provides clinical and diagnostic workflow software and Internet applications for pathology, laboratory, and radiology services to approximately 640 clients. The company reported revenues of $25.6 million last year. Cerner offers integrated clinical and financial information systems and services. A defining element of the deal is the acquisition of Dynamic’s IT in pathology, which Cerner executives believe will gain in importance with the increasing impact of genomics on healthcare.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.